A combination product containing a limonin compound (and a pharmaceutically acceptable derivative, an ester, a stereoisomer, and a salt or prodrug thereof) and a sulfonylurea drug (such as glibenclamide, gliclazide, glipizide, gliquidone, and glimepiride). The combination product is used for treatment and/or prevention of diabetes-related diseases and the like.
